CIP2A Antibody

About the Target

Phosphorylation by protein kinases and dephosphorylation by protein phosphatases are among the most prevalent mechanisms governing intracellular protein regulation and signal transduction. CIP2A (Cancerous Inhibitor of Protein Phosphatase 2A), also known as p90, is a critical regulator implicated in numerous cancer-related cellular processes, including proliferation, apoptosis, invasion, migration, epithelial-mesenchymal transition (EMT), cell cycle progression, and the development of drug resistance. Depending on the literature source, CIP2A may also be discussed as Protein CIP2A and Cancerous inhibitor of PP2A.

Reported cellular context includes chromosome and cytoplasm, which can matter when signal is compared across treatments or changing cell states. Following CIP2A across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CIP2A is commonly interpreted in the context of cancer and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans chromosome and cytoplasm, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between chromosome and cytoplasm across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CIP2A. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CIP2A reflect biology rather than handling. When interpreting CIP2A, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CIP2A trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.